SFJ Pharmaceuticals

Pleasanton, United States Founded: 2008 • Age: 18 yrs
Specialty pharmaceutical company based on partnering model
Annual revenue - Latest available
Total funding $69.5M 4 rounds
Employees 12 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About SFJ Pharmaceuticals

SFJ Pharmaceuticals is a company based in Pleasanton (United States) founded in 2008. SFJ Pharmaceuticals has raised $69.5 million across 4 funding rounds from investors including Blackstone. The company has 12 employees as of December 31, 2017.

  • Headquarter Pleasanton, United States
  • Employees 12 as on 31 Dec, 2017
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $69.5 M (USD)

    in 4 rounds

  • Latest Funding Round
    $13 M (USD), Private Equity Round

    Apr 01, 2013

  • Investors
  • Employee Count
    12

    as on Dec 31, 2017

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of SFJ Pharmaceuticals

Headcount 10-50
Employee Profiles 9
Employee Profiles
People
Marc Cobo
Executive Vice President and Chief Accounting Officer
People
Mark Wright
Head of CMC
People
Lisa Corey
Vice President, Clinical and Asset Lead
People
Robert DeBenedetto
Executive Chair Of The Board Of Directors

Unlock access to complete

Funding Insights of SFJ Pharmaceuticals

SFJ Pharmaceuticals has successfully raised a total of $69.5M across 4 strategic funding rounds. The most recent funding activity was a Private Equity Round of $13 million completed in April 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in SFJ Pharmaceuticals

SFJ Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Blackstone.

All
Venture Fund
Investor Description Founded Year Domain Location
Diversified investment management is provided across multiple asset classes.
Locked Locked Locked
Premium access

Investor details for SFJ Pharmaceuticals

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by SFJ Pharmaceuticals

Investments
Premium access

Investment portfolio details for SFJ Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - SFJ Pharmaceuticals

Premium access

Detailed financials for SFJ Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Sfj Pharmaceuticals Comparisons

SFJ Pharmaceuticals Primary company
Description
Specialty pharmaceutical company based on partnering model
Location
Pleasanton, United States
Founded Year
2008
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
12
As of 2017
Premium access

Peer comparison for SFJ Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of SFJ Pharmaceuticals

Premium access

Detailed competitors of SFJ Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Sfj Pharmaceuticals

Premium access

Complete news archive for SFJ Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SFJ Pharmaceuticals

SFJ Pharmaceuticals was founded in 2008 and raised its 1st funding round 4 years after it was founded.

SFJ Pharmaceuticals is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.

SFJ Pharmaceuticals is a funded company, having raised a total of $69.5M across 4 funding rounds to date.

As of Dec 31, 2017, the latest employee count at SFJ Pharmaceuticals is 12.

SFJ Pharmaceuticals was founded in 2008 and is headquartered in Pleasanton, United States. Operations are conducted globally in the pharmaceutical sector, utilizing a partnering model to support late-phase drug candidates across various indications. Funding and experienced clinical development resources are paired with these candidates. Two clinical programs have been completed, and four phase III oncology trials are managed across multiple therapeutic areas.

SFJ Pharmaceuticals has 1 investor. Key investors include Blackstone.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available